The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells  by Chou, Yu-Fen et al.
The Growth Factor Environment Defines
Distinct Pluripotent Ground States
in Novel Blastocyst-Derived Stem Cells
Yu-Fen Chou,1,7 Hsu-Hsin Chen,1,7 Maureen Eijpe,2,7 Akiko Yabuuchi,3 Joshua G. Chenoweth,4 Paul Tesar,5 Jun Lu,6
Ronald D.G. McKay,4 and Niels Geijsen1,*
1Harvard Stem Cell Institute, Massachusetts General Hospital, Center for Regenerative Medicine, CPZN – 4256, 185 Cambridge Street,
Boston, MA 02114, USA
2Erasmus Medical Centre, Department of Cell Biology, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
3Division of Pediatric Hematology/Oncology, Children’s Hospital Boston, One Blackfan Circle, Boston, MA, 02115, USA
4Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda,
MD 20892, USA
5Department of Genetics, Case Western Reserve University, 2109 Adelbert Road BRB-725, Cleveland, OH 44106, USA
6The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02141, USA
7These authors contributed equally to this work
*Correspondence: ngeijsen@mgh.harvard.edu
DOI 10.1016/j.cell.2008.08.035SUMMARY
Pluripotent stemcell linescanbederived fromblasto-
cyst embryos, which yield embryonic stem cell lines
(ES cells), as well as the postimplantation epiblast,
which gives rise to epiblast stem cell lines (EpiSCs).
Remarkably, ES cells and EpiSCs display profound
differences in the combination of growth factors
that maintain their pluripotent state. Molecular and
functional differences between these two stem cell
types demonstrate that the tissue of origin and/or
the growth factor milieu may be important determi-
nants of the stem cell identity. We explored how de-
velopmental stage of the tissue of origin and culture
growth factor conditions affect the stem cell pluripo-
tent state. Our findings indicate that novel stem cell
lines, with unique functional and molecular proper-
ties, can be generated from murine blastocyst
embryos. We demonstrate that the culture growth
factor environment and cell-cell interaction play a
critical role in defining several unique and stable
stem cell ground states.
INTRODUCTION
Following fertilization, the totipotent zygote undergoes rapid
cleavage divisions to form a preimplantation blastocyst embryo,
a hollow sphere in which two different cell types can be identi-
fied. An outer layer of trophectoderm cells encloses a small
group of pluripotent cells known as the inner cell mass (ICM),
from which the embryo proper will develop. At implantation,
the ICM forms the extraembryonic endoderm and the epiblast,
consisting of pluripotent cells that give rise to all embryonicgerm layers. It was the pioneering work of Martin and Evans
that demonstrated that cells in the ICM can be propagated indef-
initely in vitro in a stable pluripotent state as embryonic stem (ES)
cells, while maintaining the ability to generate all tissues of the
adult body (Evans and Kaufman, 1981; Martin, 1981; Martin
and Evans, 1975). Like their murine counterparts, human ES cells
can be propagated indefinitely in vitro and demonstrate the abil-
ity to generate derivatives of all three germ layers (Thomson
et al., 1998). Human ES cells were long thought to be equivalent
to murine ES (mES) cells, despite clear morphological differ-
ences and different growth factor requirements between these
two ES cell types.
The recent derivation of epiblast stem cells (EpiSCs) from
postimplantation epiblasts provides a new perspective on the
nature of human ES cells (Brons et al., 2007; Tesar et al.,
2007). At the molecular level EpiSCs are much more similar to
human ES cells than mES cells. EpiSCs display a flattened
two-dimensional (2D) colony morphology, which is also charac-
teristic for human ES cells, and are maintained under similar
growth factor conditions. The close match between EpiSCs
and human ES cells suggests a functional similarity between
these cells. EpiSCs display many characteristic hallmarks of plu-
ripotent stem cells such as the expression of Oct4, Sox2, and
Nanog and the ability to generate derivatives of all three germ
layers during both in vitro differentiation and in vivo teratoma
formation. But interestingly, EpiSCs fail to contribute to chimera
formation when injected into recipient blastocysts.
The above comparisons of mES cells, human ES cells, and
EpiSCs illustrate that stem cell pluripotency is not a fixed ground
state but is strongly influenced by developmental and environ-
mental context. Distinct pluripotent stem cell lines with unique
functional characteristics can be derived from different parts of
the embryo and under different growth factor conditions. For
example, the functional differences in developmental potential
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from which the stem cell line is initially derived, inner cell mass
versus epiblast, or they may be a consequence of their different
culture conditions. After all, mES cells require a combination of
Leukemia Inhibitory Factor (LIF) and Bone Morphogenetic
Protein 4 (BMP4) to maintain their undifferentiated state (Ying
et al., 2003), while the factors that support murine EpiSC or hu-
man ES cell self-renewal are a combination of bFGF, ActivinA,
or TGFb and activation of the Wnt signaling pathway (Brons
et al., 2007; Carpenter et al., 2004; Denning et al., 2006; Mallon
et al., 2006; Rosler et al., 2004; Tesar et al., 2007; Xu et al., 2005).
To dissect the effect of the growth factor milieu and the devel-
opmental age of the tissue of origin on the stem cell pluripotent
state, we derived novel stem cell lines from murine blastocyst
embryos in culture conditions previously applied to derivation
of EpiSCs from epiblast stage embryos. We designated these
cells FAB-SCs for bFGF, Activin, and BIO-derived stem cells.
We demonstrate that FAB-SCs are molecularly and functionally
distinct from both ES cells and EpiSCs. FAB-SCs express com-
mon molecular markers of stem cell pluripotency, Oct4, Nanog,
and Sox2, but unexpectedly, the cells fail to pass hallmark tests
of pluripotent differentiation such as in vitro embryoid body
formation, teratoma formation, or contribution to embryonic
development upon blastocyst transplantation. However, brief
(transient) stimulation of FAB-SCs with LIF and BMP4 induces
the potential to generate teratomas and give germline contribu-
tion in chimeric mice. Our study provides new insights into the
role of growth factor environment in reprogramming of the
stem cell pluripotent state and identifies an unexpected role for
cell-cell adhesion in this process.
RESULTS
Derivation and Characterization of Blastocyst
Stem Cells
To analyze the role of the developmental stage of the embryo on
the developmental potential of embryo-derived stem cells, we
explored whether novel cell lines could be derived from blasto-
cysts under similar growth factor conditions as previously de-
scribed for EpiSC- and human ES cell cultures (bFGF, ActivinA,
and BIO). Initial experiments using matrigel as substrate were
unsuccessful, but when instead blastocysts were hatched on
MEFs in the presence of bFGF, ActivinA, and BIO and a blocking
antibody against murine LIF, we were able to derive stable cell
lines with novel properties, which we designated FAB-SCs, for
bFGF, Activin, and BIO-derived stem cells. If the zona pellucida
was left intact, only 10% of the blastocysts hatched and upon
trypsinization and passaging of the ICM outgrowths, a third of
the hatched blastocysts yielded stable cultures that were ho-
mogenous in appearance (n = 184). Removal of the zona pellu-
cida prior to plating of the embryos improved the derivation fre-
quency significantly, as 80% of the embryos demonstrated
robust ICM outgrowth and upon passaging 30% of the original
blastocysts yielded stable FAB-SC lines (n = 99). It is interesting
to note that under FAB-SC conditions ICM expansion was no-
ticeable within 2 days after plating. In contrast, when blastocysts
are plated under mES cell conditions, ICM expansion is delayed
and occurs several days later. The difference in ICM outgrowth is
not due to differences in cell proliferation rates since FAB-SCs450 Cell 135, 449–461, October 31, 2008 ª2008 Elsevier Inc.and mES cell proliferation rates are similar (not shown). Instead,
the delay in ICM outgrowth under ES cell conditions may indicate
that ES cell lines are derived from a small subpopulation of cells
within the ICM while FAB-SC conditions allow the entire ICM to
expand. Alternatively, the delayed ICM outgrowth in ES cell
conditions may reflect a pause in cell proliferation associated
with epigenetic reprogramming events that are essential for the
derivation of mES cells (Kaji et al., 2006). While speculative,
this latter option would imply that such reprogramming does
not occur under FAB-SC conditions.
FAB-SCs Share Features with EpiSCs andmESCells Yet
Are Distinct from Both
Unlike mES cell colonies, which have a characteristic three-
dimensional appearance of tight shiny colonies, FAB-SCs grew
as monolayer colonies reminiscent of EpiSCs (Figure 1A).
Q-PCR analysis of Oct4, Sox2, and Nanog demonstrated that
all three pluripotency transcription factors were expressed in
FAB-SC lines as well as in traditional mES cells (Figure 1B). We
further confirmed the homogeneous expression and nuclear
localization of these transcription factors using immunohisto-
chemistry (Figure 1C). In addition, we confirmed the expression
of the cell-surface marker SSEA1 on the FAB-SCs (not shown),
further demonstrating that the FAB-SC cultures homogeneously
express molecular hallmarks of pluripotent cells. Although FAB-
SCs are derived on a feeder layer of MEFs, in the presence of
a blocking antibody to LIF, we cannot formally exclude that
very low residual levels of LIF signaling are required for FAB-
SC derivation. However, established FAB-SC lines can be main-
tained on gelatin or Matrigel coated dishes in serum-free media
in the absence of LIF or BMP4, with sustained expression of
pluripotent markers, demonstrating that these growth factors
are not required for the maintenance of these cells. Finally, as
we will demonstrate below, stimulation of FAB-SCs with LIF
and BMP4 induces profound permanent phenotypic changes
in these cells, arguing that FAB-SCs do not experience these
growth factors during their derivation.
FAB-SCs are derived under culture conditions similar to those
recently reported for the derivation of murine EpiSCs (Brons
et al., 2007; Tesar et al., 2007), but FAB-SCs and EpiSCs origi-
nate from different developmental stages of the embryo. To chart
similarities and differences among FAB-SCs, ES cells, and
EpiSCs, we performed global gene and microRNA (miRNA)
expression analysis on these cells.
Using a Luminex bead platform (Lu et al., 2005), we analyzed
the expression levels of >430 miRNAs in independent ES, EpiSC,
and FAB-SC clones. Heatmap analysis of these samples re-
vealed clear differences in the global miRNA profiles of these
three cell lines (Figure 1D). Interestingly, FAB-SCs express
miRNAs recently shown to be ES cell specific, such as the
miR-290 cluster (Houbaviy et al., 2003), or enriched in self-
renewing ES cells, such as miR-18a, miR-19a, and miR- 20a
(Hayashi et al., 2008). In contrast, EpiSCs express low levels of
these miRNAs. These data demonstrate that FAB-SCs express
miRNAs typical of ES cells, reflecting the blastocyst origin of
these cells. EpiSCs, on the other hand, express several miRNAs
associated with postimplantation development including miR-1
and miR-206 (associated with muscle development) and
miR-150 and miR-142 (hematopoietic differentiation) (Chen
et al., 2004; Xiao et al., 2007). The microRNA expression profiling
of these pluripotent stem cell lines underscores the unique char-
acter of FAB-SCs and reflects their early developmental origin.
EpiSCs on the other hand demonstrate the expression of
miRNAs associated with early lineage commitment, in line with
the postimplantation epiblast origin of these cells.
To further interrogate the similarities and differences between
FAB-SCs, mES cells, and EpiSCs, we performed microarray
analysis of the transcriptional profile of these different cell lines.
FAB-SCs express several known pluripotency factors, including
Oct4, Sox2, and Nanog, at levels similar to those in mES and
EpiSCs (Figure 1E). Yet, the expression of epiblast markers is ab-
sent or low in FAB-SCs compared to EpiSCs, demonstrating that
while these cells are propagated under similar growth factor con-
ditions, they are not the same (Figure 1E). FAB-SCs distinguish
themselves from ES cells as well, as they do not express many
of the genes associated with germ cell differentiation, such as
Stella, Blimp1, or Dazl, which are commonly expressed in mES
cells (Figure 1E). The mRNA expression analysis further demon-
strates that FAB-SCs represent an alternative stable stem cell
state that is distinct from both mES cells and EpiSCs.
FAB-SCs Fail to Demonstrate Pluripotency in Assays
of Development
We next tested the ability of FAB-SCs to generate derivatives of
all three germ layers in in vitro and in vivo assays of development.
Embryoid body (EB) formation is a simple and widely used
method in which aggregates of pluripotent cells initiate a differen-
tiation program that is reminiscent of early embryonic develop-
ment (Doetschman et al., 1985; Leahy et al., 1999). In the context
of the EB, molecular interactions that drive early embryonic
development are recapitulated and cells differentiate to form
ectoderm, endoderm, and mesoderm derivatives.
Surprisingly, and in stark contrast to ES cells, EBs made
from FAB-SCs remained small and failed to expand. We next
interrogated the ability of FAB-SCs to form teratomas when
injected into immunodeficient mice. FAB-SCs failed to form
Figure 1. Novel Blastocyst-Derived Stem Cells
FAB-SCs were derived as described in the Results section.
(A) Brightfield image of FAB-SCs (top panel) and mES cells (bottom panel).
(B) Q-PCR expression analysis of Oct4, Sox2, and Nanog expression on FAB-SC and ES cell as indicated. Error bars, ± standard deviation (SD).
(C) Left panels: Immunofluorescence staining of FAB-SCs for Oct4, Sox2, and Nanog as indicated. Right panels: DAPI nuclear staining.
(D) Normalized expression intensity values (scaled median ratio) were obtained from Agilent whole-genome microarrays. Three biological replicates were used for
all three cell types.
(E) Hierarchy clustering of MicroRNA profiles of MEF, mES, EpiSC, and FAB-SC cell lines.Cell 135, 449–461, October 31, 2008 ª2008 Elsevier Inc. 451
any teratomas at 3 months after injection (n = 20), whereas
teratomas formed within 1 month in all mice injected with ES
cells (n = 5).
Pluripotency is characterized by the ability of a stem cell to self-
renew indefinitely while maintaining the capacity to differentiate
into derivatives of all three germ layers. While FAB-SC cultures
display sustained expression of hallmark molecular markers of
pluripotency >30 passages (Figure 1C), the cells fail to pass stan-
dard in vitro and in vivo tests of pluripotency such as EB differen-
tiation or teratoma formation. As such, FAB-SCs are also molec-
ularly and functionally distinct from primitive epiblast-like cells
(EPL cells) that are derived when ES cells are cultured in the
presence of HEPG2 conditioned medium (Rathjen et al., 1999).
Epiblast marker genes, which are expressed in EPL cells, are
low or absent in FAB-SCs, and in contrast, FAB-SCs express
the ICM marker Gbx2 and EPL cells do not. In addition, EPL cells
are capable of forming teratomas, while FAB-SCs are not,
excluding the possibility that FAB-SCs are EPL cells.
Growth Factor Stimulation Induces FAB-SC
Pluripotency
To examine the influence of the growth factor milieu on FAB-SC
pluripotency, we explored the effect of LIF and BMP4 stimulation
on the ability of FAB-SCs to generate teratomas (Figure 2A).
To ensure a homogeneous FAB-SC population, we used flow
cytometry to sort single-cell clones of FAB-SCs containing
a GFP transgene into 96-well plates and visually confirmed the
presence of a single cell in each well. Clonal FAB-SCs were
stimulated with LIF (100 ng/ml) and BMP4 (50 ng/ml) for
1 week and injected subcutaneously into NOD-SCID mice
(1 3 106 cells, n = 7) to assess their teratoma-forming potential.
While none of the native FAB-SC clones gave rise to teratomas,
injection of LIF/BMP4-stimulated FAB-SC clones resulted in the
formation of teratomas in all recipients (3 independent clones,
n = 7 for each clone). H&E staining and immunofluorescent
detection of markers of germ layer differentiation demonstrated
that the teratomas generated by the LIF/BMP4-stimulated
Figure 2. LIF and BMP4 Stimulate FAB-SC Teratoma Formation
(A) Schematic representation of FAB-SC derivation (with bFGF/ActivinA and BIO), LIF/BMP4-stimulated FAB-SCs cultured in the presence of LIF and BMP4, and
reverted FAB-SCs, which are again maintained in bFGF/ActivinA and BIO.
(B) H&E staining of teratomas generated from a clonal FAB-SC line stimulated with LIF/BMP4 (left panels) or stimulated and subsequently cultured for 7 days in
FAB-SC conditions (right panels). Derivatives of all three germ layers are observed as indicated.
(C) Immunohistochemistry analysis of markers of ectoderm (Nestin, Tubulin b3 [Tubb3]), mesoderm (Smooth Muscle Actin, [SMA]), or endoderm (FoxA2).
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FAB-SCs displayed derivatives of all three embryonic germ-
layers (Figures 2B and 2C, left panels), demonstrating that brief
culture in LIF/BMP4 induces FAB-SC developmental potential.
Interestingly, when the LIF/BMP4-stimulated FAB-SCs were
returned back to the original FAB-SC growth factor conditions
and cultured for another week, these ‘‘reverted’’ FAB-SCs
retained the ability to generate teratomas (Figures 2B and 2C,
right panels). Thus, the FAB-SC pluripotent state, induced
by transient LIF/BMP4 stimulation, is retained even when the
LIF/BMP4 stimulus is subsequently removed.
Blastocyst Contribution by FAB-SCs
To further explore our observation that LIF/BMP4 stimulation in-
duced FAB-SC pluripotency, we examined the effect of growth
factor stimulation on the ability of FAB-SCs to form chimeras
upon transfer into recipient blastocysts. Control and LIF/BMP4-
stimulated FAB-SCs, expressing the GFP transgene de-
scribed above, were injected into blastocyst embryos and their
integration into the recipient blastocyst was monitored over
time. While the LIF/BMP4-exposed FAB-SCs integrated with
the cells of the ICM within 6 hr after injection, unstimulated
FAB-SCs remained dispersed in the blastocyst cavity, revealing
that integration of FAB-SCs into the recipient embryos was
impaired (Figure 3A).
To further analyze the developmental potential of FAB-SCs
before and after growth factor stimulation, we transferred the
embryos into pseudopregnant females and analyzed chimerism
by the expression of the GFP transgene and/or coat color. No
chimerism was observed in any of the >320 pups from blasto-
cysts injected with 10–12 FAB-SCs each. Sectioning and immu-
nohistochemistry staining of the embryos using an anti-GFP
antibody revealed no GFP contribution to the recipient embryos
at mid-gestation (E9.5–E11.5). In contrast, even brief 48 hr stim-
ulation of FAB-SCs with LIF and BMP4 induced the ability of
these cells to form chimeras. Although the chimeric frequency
was low (7 out of 254 pups), the chimeras demonstrated high
(40%–90%) FAB-SC contribution (Figure 3B, top panel). Mating
with a wild-type female showed transmission of the FAB-SC-
derived GFP transgene to the offspring, demonstrating that
LIF/BMP4-stimulated FAB-SCs are capable of germline contri-
bution as well (Figure 3B, middle panel). These embryo chime-
rism experiments were repeated with single-cell-derived clonal
Figure 3. Growth Factor Stimulation Induces FAB-SC Chimera Formation and Germline Contribution
(A) Temporal analysis of the integration of GFP-transgenic FAB-SC before and after LIF/BMP4 stimulation into recipient blastocysts. Integration of FAB-SCs and
LIF/BMP4-stimulated FAB-SCs was monitored at 1, 3, and 6 hr after injection as indicated.
(B) Top panel: High contribution chimera derived from LIF/BMP4-stimulated FAB-SC (48 hr stimulation); arrows indicate agouti coat color chimerism. Bottom
panel: GFP+ offspring of the FAB-SC chimera, demonstrating germline transmission.
(C) Chimera from clonal FAB-SCs stimulated for 7 days with LIF/BMP4.
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FAB-SC lines. Again, no chimerism was observed upon blasto-
cyst transfer of clonal FAB-SCs (n = 160). However, LIF/BMP4
stimulation of clonal FAB-SCs for 7 days induced the ability of
these cells to contribute to recipient embryos with a frequency
similar to the parental cell line (not shown).
Finally, we analyzed whether FAB-SCs exposed to LIF/BMP4
for 1 week would contribute to chimera formation after further
culture in bFGF, ActivinA, and BIO. Clonal LIF/BMP4-stimulated
FAB-SCs were cultured for an additional 7 days in FAB-SC me-
dia containing bFGF, ActivinA, BIO, and anti-LIF antibody and
subsequently injected into recipient blastocyst embryos. GFP
contribution by the injected reverted FAB-SCs was detected
in 4 out of 123 embryos analyzed, with chimerism ranging from
20%–80% (Figure 3C), demonstrating that pluripotency is
retained even after removal of the LIF/BMP4 signal.
The above data demonstrate that LIF/BMP4 stimulation of
FAB-SCs induces their ability to contribute to chimera formation.
The relatively low number of chimeras obtained suggests
that only a fraction of the FAB-SCs undergoes full growth-fac-
tor-mediated conversion to the pluripotent state. Robust con-
tribution by cells that do successfully undergo pluripotent
conversion, including contribution to the germline, indicates
however that the induced cells are truly pluripotent. Importantly,
the ability of FAB-SCs to display this effect at the clonal level
demonstrates that the LIF/BMP4-stimulated chimera formation
is the result of an induction of FAB-SC pluripotency rather than
clonal selection of ‘‘competent’’ cells from a heterogeneous
starter population.
E-Cadherin Is Induced by Transient LIF/BMP4
Stimulation of FAB-SCs
The unique properties of FAB-SCs allowed us to further probe
the molecular mechanism behind the induction of FAB-SC pluri-
potency by growth factor stimulation. Microarray comparison of
the FAB-SC gene expression profile of three independent clonal
FAB-SC lines with the expression profile of LIF/BMP4-stimulated
FAB-SCs demonstrated profound changes in gene expression
(Figure 4A, upper panel). Comparison of FAB-SCs to cells that
were transiently stimulated with LIF/BMP4 and subsequently
reverted to the original growth conditions of bFGF, ActivinA,
and BIO enabled us to focus on gene expression changes
linked to the induction of pluripotency (Figure 4A, lower panel).
We compared the gene expression profiles of FAB-SCs, the
LIF/BMP4-stimulated FAB-SC, and the growth-factor-reversed
FAB-SCs and searched for genes that were up- or downregu-
lated at least 3-fold by LIF/BMP4 stimulation and remained
altered in the reverted FAB-SCs. Only a handful of genes dis-
played this expression profile consistently in three independent
FAB-SC clones (Figure 4B). Four ‘‘hits’’ were genes involved in
RNA translation and two were genes with unknown function.
Cdh1 (E-cadherin) displayed the most profound induction, as it
demonstrated a 4- to 6-fold upregulation on all seven features
Figure 4. E-Cadherin Is Induced by LIF/BMP4 Stimulation of FAB-SC
(A) Microarray comparison of gene expression of FAB-SC and LIF/BMP4-stimulated FAB-SC (upper panel) or FAB-SC and growth-factor-reversed FAB-SC
(lower panel).
(B) Heatmap of genes permanently upregulated by LIF/BMP4 stimulation of FAB-SC.
(C) Western blot analysis of E-cadherin expression in FAB-SC, LIF/BMP4-stimulated FAB-SC, and growth-factor-reverted FAB-SC.
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of the microarray. Western analysis of E-cadherin expression in
FAB-SCs, LIF/BMP4-stimulated FAB-SCs, and reverted FAB-
SCs demonstrated that while FAB-SCs express low levels of
E-cadherin, LIF/BMP4 stimulation results in upregulation of
E-cadherin expression to levels comparable to those observed
in mES cells; this upregulation was sustained in the reverted
FAB-SCs (Figure 4C).
E-Cadherin Is a Critical Regulator of FAB-SC
Pluripotency
To further analyze the function of E-cadherin in pluripotent stem
cells, we generated lentiviral shRNA hairpins to examine the ef-
fect of downregulation of E-cadherin expression on the ability
of FAB-SCs to generate teratomas. shRNA hairpins were tested
to functionally downregulate E-cadherin expression in mES cells
(Figure S1A available online). While E-cadherin expression was
unaffected in the control hairpin, two E-cadherin hairpins
(Cdh1-SH3 and Cdh1-SH4) demonstrated >90% downregula-
tion of E-cadherin expression and were selected for further
experiments. Functional knockdown of E-cadherin expression
was tested in a cell aggregation assay. Cadherins mediate
cell-cell adhesion through homotypic interactions. Two cell pop-
ulations expressing similar levels of the same cadherin will form
homogeneous aggregates, while dissimilarities in the nature or
level of cadherin expression will result in segregation of the two
cell types (Gibralter and Turner, 1985; Takeichi et al., 1981). While
ES cells transduced with the control shRNA hairpin formed ho-
mogeneous aggregates when mixed with wild-type ES cells, ES
cells expressing the E-cadherin hairpins did not mix with the
Figure 5. E-Cadherin Regulates FAB-SC Pluripo-
tency
(A) FAB-SCs constitutively expressing a GFP transgene
were transduced with control vector or shRNA to knock
down E-cadherin. A tdTomato reporter gene was coex-
pressed from the lentiviral shRNA vector to allow identifi-
cation of knockdown cells. Cdh1 knockdown results in
FAB-SC differentiation (middle top panel, arrowhead).
(B) FAB-SCs were transduced with either control vector or
Cdh1 expression vector and 1 3 106 cells were injected
subcutaneously into NOD-SCID mice. Tumors were ana-
lyzed for germlayer differentiation 1 month after injection
of the cells. Top panels: H&E staining of teratomas gener-
ated from Cdh1-FAB-SCs. (I) Keratinocyte, (II) adipocyte,
(III) gut. Lower panels: Immunohistochemistry analysis of
markers of (IV) Nestin, ectoderm, (V) Smooth Muscle Actin,
mesoderm, and (V) FoxA2, endoderm.
wild-type cells but instead aggregated in spa-
tially separate domains, demonstrating func-
tional consequences of E-cadherin knockdown
in these cell lines (Figure S1B). Next we explored
the effect of knockdown of E-cadherin expres-
sion on LIF/BMP4-stimulated FAB-SCs, but we
were unable to establish stable clones using
the E-cadherin knockdown hairpins. Transduc-
tion of LIF/BMP4-stimulated FAB-SCs with the
control vector yielded stable clones expressing
the tdTomato reporter gene present in the lenti-
viral shRNA vector (Figure 5A). Loss of E-cadherin has been
reported to induce anoikis-mediated apoptosis in certain cancer
cell lines, yet no difference in apoptosis was observed between
the control and E-cadherin knockdown samples (not shown).
When we analyzed the transduced cells by fluorescent micros-
copy, however, we observed a striking difference in the morphol-
ogy of the E-cadherin knockdown cells compared to control. In
the control sample, tdTomato-positive (lentiviral-transduced)
cells proliferated as undifferentiated colonies (Figure 5A, lower
panels). In contrast, stimulated FAB-SC cells transduced with
the E-cadherin hairpins had a fibroblast-like morphology, dem-
onstrating that downregulation of E-cadherin resulted in rapid
FAB-SC differentiation (Figure 5A, upper panels, arrows).
Induction of FAB-SCPluripotency by Ectopic Expression
of E-Cadherin
The upregulation of E-cadherin expression in FAB-SCs following
LIF/BMP4 stimulation correlates with the induction of the ability
of these cells to form teratomas containing derivatives of all three
germ layers. We next examined whether this upregulation of E-
cadherin expression is sufficient to induce the teratoma-forming
potential of FAB-SCs. FAB-SCs transduced with a lentiviral vec-
tor expressing E-cadherin formed teratomas in immunodeficient
mice after 1 month (5 out of 7), whereas none of 7 mice injected
with control FAB-SCs developed teratomas. H&E staining and
immunofluorescent detection of markers of germ layer differen-
tiation demonstrated that the teratomas generated by the E-cad-
herin FAB-SCs displayed derivatives of all three embryonic germ
layers (Figure 5B). These data demonstrate that overexpression
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of E-cadherin alone is sufficient to induce robust teratoma-
forming potential in FAB-SCs and suggest that a key target of
LIF/BMP4 stimulation is upregulation of E-cadherin expression.
Accelerated ES Cell Differentiation in the Absence
of E-Cadherin Expression
Above data demonstrate that E-cadherin plays an important role
in regulating the FAB-SC pluripotent state. To test whether abro-
gation of E-cadherin expression would compromise the pluripo-
tency of mES cells, we generated stable mES cell lines express-
ing the control or Cdh1 knockdown hairpins. Downregulation of
E-cadherin expression in mES cells changes the morphology of
the cells from the tight, three-dimensional colony shape to more
flattened colonies of loosely connected cells, very much resem-
bling FAB-SCs (Figure S2A). ES cells stably expressing the
E-cadherin hairpins could be propagated for over 20 passages,
and the proliferation and apoptotic rates between the control
and E-cadherin knockdown ES cell lines were comparable (see
Figure 6D below), suggesting that knockdown of E-cadherin
did not impair ES self-renewal, proliferation, or apoptosis. Using
immunohistochemistry we analyzed the expression of Oct4 in
the control and E-cadherin knockdown ES cell lines (Figure S2B).
No differences in the level, localization, or percentage of Oct4
expression were observed between control and E-cadherin
knockdown ES cells. Furthermore, even cells that demonstrated
a rounded-up clustered colony morphology were expressing
Oct4 (arrowheads, Figure S2B). Thus, while knockdown of
E-cadherin expression in traditional mES cells results in a change
in morphology and loss of tight adhesion of the ES cells, loss of
E-cadherin does not impair ES cell self-renewal. Like FAB-SCs,
the E-cadherin knockdown ES cells formed small EBs (Figures
6A and 6B). Moreover, whereas E-cadherin knockdown ES cells
form teratomas upon subcutaneous injection into NOD-SCID
mice, loss of E-cadherin expression results in a profound reduc-
tion in teratoma size, as measured by the weight of the teratomas
(Figure 6C). Analysis of the teratomas revealed multilineage dif-
ferentiation, however, indicating that differentiation of the Cdh1
knockdown ES cells per se was not impaired (not shown). The
reduced size of the E-cadherin knockdown EBs was not due to
decreased proliferation or increased apoptosis of these cells
(Figure 6D). Finally we analyzed the expression of pluripotency
markers Oct4, Sox2, and Nanog before and during differentiation
of control ES cells or the E-cadherin knockdown cell lines. While
we observed no difference in the downregulation of Oct4 and
Sox2 expression, western blot analysis revealed an accelerated
loss of Nanog protein expression in the absence of E-cadherin
expression as compared to control cells (Figure 6E). The rapid
loss of Nanog expression in the E-cadherin knockdown cells
was also observed when we monitored Nanog RNA levels by
Q-PCR (Figure 6F). Oct4, Sox2, and Nanog have been shown
to bind to promoter elements of genes involved in early cell
fate decisions (Boyer et al., 2005, 2006). The concerted binding
of these transcription factors mediates the recruitment of the
polycomb silencing complex, thereby suppressing gene expres-
sion. Thus part of the role Oct4, Sox2 and Nanog play in ES cell
self-renewal is to prevent the expression of genes associated
with differentiation, such as genes in the Hox-cluster. Since
loss of E-cadherin results in early downregulation of Nanog456 Cell 135, 449–461, October 31, 2008 ª2008 Elsevier Inc.upon cell differentiation, we analyzed the expression of HoxA1
and HoxB1 in these cells. Upregulation of HoxA1 and HoxB1 is
a hallmark sign of cell differentiation toward the somatic lineages
and distinguishes pluripotent cells from early somatic cells in the
primitive epiblast (Saitou et al., 2002; Yabuta et al., 2006). While
we observed no upregulation of HoxA1 expression during early
differentiation of control or E-cadherin knockdown ES cells,
HoxB1 expression was upregulated prematurely in both E-cad-
herin knockdown cell lines compared to control (Figure 6F). To-
gether our data demonstrate that loss of E-cadherin expression
results in rapid differentiation of FAB-SCs, and while mES cells
can maintain their pluripotent state in the absence of E-cadherin
expression, they demonstrate an accelerated loss of Nanog
expression and premature upregulation of HoxB1 expression
upon induction of differentiation.
DISCUSSION
We have derived a novel stem cell line from murine blastocyst
embryos using growth factor conditions previously reported for
murine EpiSCs and human ES cells (Brons et al., 2007; Ginis
et al., 2004; Tesar et al., 2007). Transcriptome and miRNA ex-
pression analyses demonstrate that EpiSCs, mES cells, and
now FAB-SCs represent distinctive stem cell lines derived from
early murine embryos. Our data demonstrate that stem cells
can exist in a number of distinct metastable epigenetic states,
which each display unique phenotypic properties that are deter-
mined by the growth factor environment and the developmental
stage of the embryo from which the cell line is derived (Table 1).
FAB-SCs may be trapped in a state of ‘‘partial pluripotency,’’
akin to the partially reprogrammed states identified in cultures
of induced pluripotent stem cells (iPS cells). In a seminal paper
Takahashi and Yamanaka demonstrated that introducing four
transcription factors, Oct4, Sox2, c-Myc, and Klf4, is sufficient
to reprogram fibroblasts into pluripotent stem cells (Takahashi
and Yamanaka, 2006). The authors selected successfully re-
programmed iPS cells by their re-expression of an ES cell-spe-
cific Fbx15 reporter. While these initial iPS cells displayed the
ability to generate teratomas with derivatives of all three germ
layers and contributed to somatic lineages in chimera experi-
ments, they failed to contribute to the germline, indicating that
full pluripotency was not achieved. Subsequent application of
alternative reporter genes demonstrated that the pluripotent po-
tential of the derived iPS cell lines is determined by the method of
iPS colony selection, and germline-competent iPS cells can be
obtained if cells are selected for the re-expression of Nanog or
Oct4 transcription factors (Maherali et al., 2007; Meissner
et al., 2007; Okita et al., 2007) or when selection is omitted en-
tirely (Stadtfeld et al., 2008). These data suggested that iPS cells
can exist in a stable, partially reprogrammed state. Indeed, a re-
cent report demonstrates that incomplete reprogramming of
chromatin marks associated with somatic lineages in some iPS
lines results in failure of these iPS cells to repress lineage-spec-
ifying transcription factors and hampers their pluripotent poten-
tial (Mikkelsen et al., 2008). Similarly, our FAB-SCs may be in
a stable ground-state of ‘‘near pluripotency’’ that can be reprog-
rammed to full pluripotency by altering the growth factor milieu.
The role and mechanism of growth factor signaling in the
reprogramming process has thus far not been recognized, and
our FAB-SC system uniquely allows the dissection of this
process at the molecular level.
We identified E-cadherin as a candidate gene that is induced
upon transient LIF/BMP4 stimulation of FAB-SCs. E-Cadherin
plays an essential role during preimplantation embryonic devel-
opment. In its absence, proper cell polarization is absent and
trophectoderm formation is impaired (Larue et al., 1994; Rieth-
macher et al., 1995). Remarkably, embryo compaction is unaf-
fected in E-cadherin null embryos, but the cells fail to sustain
the compacted state and do not form a blastocyst. E-Cadherin
mutant embryos fail to hatch and do not demonstrate the typical
compacted ICM morphology but instead form clusters of
rounded cells, much like bunches of grapes (Larue et al.,
1994), and shRNA knockdown of E-cadherin expression in
mES cells results in similar colony morphology. In addition,
Figure 6. Loss of E-Cadherin Expression Compromises EB and Teratoma Formation by Accelerating ES Cell Differentiation
(A) Representative images demonstrating EB differentiation of wild-type and E-cadherin knockdown ES cells. Loss of cadherin expression results in small EB size
compared to the wild-type EBs.
(B) Bar-graph analysis of the sizes of wild-type or E-cadherin knockdown EBs.
(C) The effect of loss of E-cadherin expression on teratoma formation. Plotted is the weight (in grams) of seven teratomas of wild-type and seven each of two
independent E-cadherin knockdown ES cell lines. Loss of E-cadherin results in a profound reduction in teratoma size.
(D) Analysis of apoptotic frequency in control and E-cadherin knockdown cells. Stable ES cell lines transduced with control vector or two independent E-cadherin
knockdown hairpins were analyzed by flow cytometry for AnnexinV staining. The ES cells expressed a tdTomato fluorescent reporter gene to distinguish them
from the MEF feeder cells. Top panels: AnnexinV-FITC staining of control and two E-cadherin knockdown ES cell lines. The percentage of AnnexinV-positive cells
is indicated. Bottom panels: AnnexinV staining of the same cell lines after 7 days of monolayer differentiation of the cells.
(E) E-cadherin downregulation results in early loss of Nanog expression and premature upregulation of HoxB1. Western blot analysis of Nanog protein expression
during differentiation of control ES cells (top) and two independent E-cadherin knockdown ES cell lines (middle and lower panels). Numbers indicate days of
differentiation.
(F) Left: Q-PCR analysis of the Nanog RNA levels in the same samples. Right: Q-PCR analysis of HoxB1 expression in the same samples.Cell 135, 449–461, October 31, 2008 ª2008 Elsevier Inc. 457
E-cadherin mutant ES cells fail to generate organized tissue
structures in teratoma assays (Larue et al., 1996). Ectopic ex-
pression of E-cadherin or N-cadherin in E-cadherin mutant ES
cells restored their ability to generate defined teratomas and
revealed an unexpected differential effect on the type of tissue
formed by the expression of these two cadherins, demonstrating
that cell-cell adhesion plays an important role in directing tissue
differentiation. Our data extend these observations by demon-
strating that E-cadherin plays an active role in regulating the
stem cell pluripotent state itself.
The differential need for E-cadherin expression for the mainte-
nance of pluripotency in FAB-SCs and mES cells may be due to
redundant effects of N-cadherin expression in mES cells. Indeed,
a knockin ES cell line in which N-cadherin cDNA was inserted into
the E-cadherin locus demonstrated that while N-cadherin failed
to correct the trophectoderm phenotype of the E-cadherin
mutant embryos, it did rescue ES cell colony morphology (Kan
et al., 2007). Since FAB-SCs only express E-cadherin, downregu-
lation of E-cadherin expression results in rapid differentiation. In
contrast, mES cells express low levels of N-cadherin that may
act redundantly to rescue stem cell self-renewal. Upon knock-
down of E-cadherin expression, differentiating mES cells display
premature downregulation of Nanog expression concomitant
with an early upregulation of HoxB1 expression. We conclude
that E-cadherin plays a critical role in regulating the stem cell
pluripotent state and prevents premature differentiation by regu-
lating Nanog expression.
The molecular link between E-cadherin and Nanog expression
is unknown and may be founded in the close cell-cell contact
mediated by E-cadherin. For example, DE-cadherin is an impor-
tant component of the Drosophila germ cell niche, where it an-
chors germline stem cells to the somatic component of the niche
(Song and Xie, 2002). Close contact between the stem cells and
the soma assures that the stem cells receive high levels of
growth factor signals that are required for their self-renewal
(Song and Xie, 2002; Tulina and Matunis, 2001; Yamashita
et al., 2003). It is interesting to hypothesize that pluripotent
stem cells, such as FAB-SCs and ES cells, in a similar fashion
require cadherin-mediated cell-cell contacts for optimal self-
renewal, possibly by an unknown paracrine mechanism. Alterna-
tively, E-cadherin itself could provide essential downstream
signals that mediate the regulation of Nanog expression and
maintenance of pluripotency. E-Cadherin associates with b-cat-
enin, which serves dual roles as mediator of cell adhesion and
transcriptional regulator. b-catenin activation through the Wnt
signaling pathway has been implicated in ES cell self-renewal
(Sato et al., 2004). In addition, TCF binding sites were recently
found to colocalize with many Oct4 and Nanog binding sites in
the genome, indicating that the Wnt-b-catenin signaling pathway
is integral to the pluripotency circuitry mediated by these tran-
scription factors (Cole et al., 2008). E-Cadherin may fine-tune
this pathway by modulating intracellular b-catenin levels. Addi-
tional signaling pathways are known to be activated by cadherin
stimulation and dissection of the molecular associations between
the growth factor environment, The expression of E-cadherin by
epithelial cells has been postulated as a reason for why transcrip-
tion factor-induced reprogramming of epithelia is more efficient
than the generation of iPS cells from fibroblasts, which lack
Table 1. Origin, Culture Conditions, and Functional Properties of Different Pluripotent Stem Cell Lines
Cell Line Origin Growth Factor Conditions Teratoma Formation Chimera Formation Reference
Murine ES Blastocyst LIF, BMP4 All germ layers Somatic and germline
contribution
(Evans and Kaufman, 1981;
Martin and Evans, 1975)
Murine EpiSC Epiblast bFGF, Activin All germ layers No (Brons et al., 2007;
Tesar et al., 2007)
Human ES Blastocyst bFGF, Activin, (BIO),
MEF conditioned media
All germ layers Not tested (Thomson et al., 1998)
FAB-SC Blastocyst bFGF, Activin, BIO No No This report




Murine IPS cells Somatic cells LIF, BMP4 All germ layers Somatic and germline
contribution
(Maherali et al., 2007;
Meissner et al., 2007; Okita
et al., 2007; Takahashi
and Yamanaka, 2006)
Human IPS cells Somatic cells bFGF, serum, MEF
conditioned media
All germ layers Not tested (Park et al., 2008;
Takahashi et al., 2007;
Yu et al., 2007)




All germ layers Somatic and germline
contribution
(Matsui et al., 1992;
Resnick et al., 1992)
Human EG cells Embryonic gonad LIF, bFGF, and Forskolin All germ layers Not tested (Shamblott et al., 1998)
Murine mGS cells Postnatal testis Derivation: GDNF, LIF
Maintenance: LIF and
fetal bovine serum
All germ layers Somatic contribution (Guan et al., 2006;
Kanatsu-Shinohara et al.,
2004; Seandel et al., 2007)
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E-cadherin expression (Aoi et al., 2008). Thus, unraveling the role
of the growth factor environment and cell-cell interactions in the
induction and maintenance of FAB-SC pluripotency may serve as
a paradigm for other systems of epigenetic reprogramming.
EXPERIMENTAL PROCEDURES
Mouse Strains and ES Cells
C57BL/6-TGN(ACTbEGFP) were from Jackson Laboratories, Bar Harbor, ME,
USA (Okabe et al., 1997). 129SvEv were from Taconic, Germantown, NY, USA.
ES and FAB-SC cell lines were derived from F1 cross between C57BL/6-
TGN(ACTbEGFP)1Osb and 129SvEv. Antibodies used Oct4 (Santa Cruz),
Sox2 (Chemicon), Nanog (Abcam), and E-cadherin 1:100 (Cell Signaling
Technology).
Derivation and Maintenance of FAB-SC Cell Lines
E3.5 blastocysts were obtained from C57/BL6 female 3 129SvEv-EGFP male
mice. Briefly, blastocysts were flushed from uterus with M2 media (Chemicon)
and placed on MEFs in media that consisted of DMEM, 15% KOSR, 2 mM
L-glutamine, 1% nonessential amino acids, 100 U of penicillin, 100 mg of strep-
tomycin, 1 mM Sodium Pyruvate (all from Invitrogen), 0.1 mM b-mercaptoetha-
nol, 50 mg/ml ascorbic acid, 100 mg/ml FE-saturated transferring (all from
Sigma). For the maintenance of FAB-SCs and reverted FAB-SCs, growth
factors were added: 1 ng/ml bFGF (R&D systems), 50 ng/ml human ActivinA
(Peprotech), 0.5 mM BIO (Sigma), and 100 ng/ml LIF-blocking antibody (R&D
systems). Seven days after initiation of explant culture, blastocyst outgrowths
were dissociated with Trypsin-EDTA (Invitrogen) and transferred to new wells
containing MEFs. The established FAB-SC lines were passaged every other
day at a subculture ratio of 1:10. The LIF/BMP4-stimulated FAB-SCs were cul-
tured in the same basal media containing 100 ng/ml rmLIF and 50 ng/ml
rhBMP4 (R&D systems).
miRNA Expression Profiling
MicroRNA expression profiling was performed as described (Lu et al., 2008; Mi
et al., 2007). One microgram total RNA was used for profiling using the plate-
capture method of labeling and using the bead-based platform for detection.
MicroRNAs were captured using plates coupled with oligonucleotides anti-
sense to microRNAs, ligated with adaptors, reverse-transcribed and amplified
through PCR, incorporating biotin as a label. Labeled microRNAs were hybrid-
ized to detecting oligonucleotides on colored beads before detection using
flow cytometry on a Luminex 100IS machine. Median fluorescence intensity
was used for each microRNA as a measure of expression. Data were prepro-
cessed as described (Lu et al., 2005). Briefly, samples were normalized
assuming the same total fluorescence intensity. Data were then log2-trans-
formed and thresholded at 5. Hierarchical clustering was performed in matlab
after filtering out microRNAs that were detected in the noise range (with
maximum expression in any sample of less than 7.25).
Culture of ES-EpiSC Cells
Cells were maintained on GFR-matrigel (BD Biosciences) or Laminin (Sigma)
as indicated in FAB-SC medium (DME, 15% KOSR [Invitrogen], 0.1 mM
nonessential amino acids [Invitrogen], 2 mM glutamine, penicillin/streptomycin
[Invitrogen], 0.1 mM b-mercaptoethanol, 200 mg/ml iron-saturated transferrin
(Sigma), and 50 mg/ml ascorbic acid [Sigma]), supplemented with growth
factors: for ES cells 100 ng/ml LIF and 50 ng/ml BMP4 (R&D Systems), for
ES-EpiSC and FAB-SC cells 50 ng/ml recombinant human ActivinA (Pepro-
tech), 1 ng/ml bFGF (R&D Systems), 0.5 mM BIO (Sigma), and 500 ng/ml noggin
(R&D Systems). For EB differentiation, cells were trypsinized, collected in EB
medium (IMDM/15% IFS, 200 mg/ml iron-saturated transferrin [Sigma],
4.5 mM monothiolglycerol [Sigma], 50 mg/ml ascorbic acid [Sigma], and
2 mM glutamine). Cells were collected and plated in hanging drops at 300 cells
per 25 ml droplet in an inverted bacterial petri dish. EBs were collected from the
hanging drops at day 3 and transferred into 10 ml EB medium in slowly rotating
10 cm Petri dishes. At day 3, EBs were fed by exchanging half of their spent
medium. Cells were harvested by lysis in Trizol (Invitrogen), followed by RNA
extraction and cDNA synthesis for Q-PCR analysis of gene expression.Blastocyst Injection
Blastocysts were collected from the uterine horns of superovulated C57BL/6
females that were mated with C57BL/6 males. Ten to twelve cells were
injected per recipient blastocyst. Upon injection, blastocysts were transferred
into the uterus of pseudopregnant recipient CD-1 females who were plugged
2.5 days earlier by vasectomized CD-1 males.
Microarray Analysis
For genome-wide expression analysis we compared the expression profile of
three independent clonal FAB-SC lines as well as the LIF/BMP4-stimulated
FAB-SCs and reverted FAB-SCs from these lines. Total RNA was extracted
using Trizol reagent (Invitrogen) and labeled and hybridized to Agilent Whole
Mouse Genome Oligo 4X44K Microarrays (one-color platform) according to
the manufacturer’s protocols. mES and EpiSC expression data were from
the geo omnibus (Tesar et al., 2007). The gene expression results were
analyzed using GeneSifter and/or Genespring microarray analysis software.
Single-Cell Cloning of FAB-SCs
FAB-SCs were dissociated by 0.05% Trypsin-EDTA at 37C. Cell suspension
was filtered through 40 mm cell strainer (BD bioscience) and single cells were
FACS (FACS Aria, BD Bioscience) sorted individually into 96 wells with
feeders. Presence of single cell in each well was confirmed visually. The
subclones were subsequently propagated using standard FAB-SC culture
conditions.
FACS Analysis
Cells were collected by trypsinization and resuspended in ice-cold RPMI +
0.5% FBS. Cells were incubated with the antibodies against the indicated sur-
face antigens for 30 min at 4C. Anti-SSEA1 and anti-SSEA2 were from the Hy-
bridoma bank at the University of Iowa; TRA-1-60 and TRA-1-81 anti-human
ES cell antibodies were from Chemicon. The cells were washed twice with
RPMI/0.5% FBS and incubated with PE-conjugated rat anti-mouse IgM for
30 min at 4C. Cells were washed twice with RPMI/0.5% FBS, resuspended
in RPMI/0.5% FBS, and analyzed on a Becton Dickinson FACSCalibur
analyzer or sorted using a Becton Dickinson FACSAria cell sorter.
Lentiviral shRNA Knockdown
The target sequences for murine E-cadherin RNAi knockdown were selected
and the DNA oligos were designed using the pSicoligomaker 1.5 program
(http://web.mit.edu/jacks-lab/protocols/pSico.html). The target sequences
were GGAGATGCAGAATAATTAT (Cdh1 sh3) and GAAGAGAACATTCTA
(Cdh1 sh4). For the lentiviral vector, we used a modified version of pLentiLox
3.7, in which the GFP is replaced by a tdtomato selection marker (gift from
Dr. L. Daheron). The DNA oligos for the small hairpins were cloned into the
XhoI and HpaI sites in the pLentiLox-tdtomato vector as described in http://
web.mit.edu/jacks-lab/protocols/pll37cloning.htm. Lentivirus was produced
in 293-FT cells (Invitrogen) according to the manufacturer’s protocol and
concentrated by centrifugation at 18000 rpm for 2 hr.
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